Cannabinoids: from pot to lab
- PMID: 30275754
- PMCID: PMC6158663
- DOI: 10.7150/ijms.27087
Cannabinoids: from pot to lab
Abstract
Cannabis is becoming increasingly present in our society. In recent years, the line between the natural (cannabis) and the synthetic (synthetic cannabinoids), the recreational (cannabis) and the medical (pharmaceutical cannabinoids and medical cannabis) has been crossed. In this paper we review some of the novel aspects of cannabis and cannabinoids in relation to their legal situation, changes in their composition and forms of cannabis use, the concept of medical cannabis, and synthetic cannabinoids as new psychoactive substances (NPS). We have also analyzed serious adverse reactions and intoxications associated with the use of synthetic cannabinoids, as well as the latest developments in the research of pharmaceutical cannabinoids.
Keywords: Cannabis, Delta-9-tetrahydrocannabinol (THC), Cannabidiol (CBD), Medical cannabis; Synthetic cannabinoid.
Conflict of interest statement
Competing Interests: The authors have declared that no competing interest exists.
References
-
- UNDOC (United Nations Office on Drugs and Crime) World Drug Report 2017. https://www.unodc.org/wdr2017/index.html.
-
- EMCDDA (European Monitoring Centre for Drugs and Drug Addiction) European Drug Report 2017: Trends and Developments. http://www.emcdda.europa.eu/publications/edr/trends-developments/2017. - PubMed
-
- EMCDDA (European Monitoring Centre for Drugs and Drug Addiction) Statistical Bulletin 2018. https://www.emcdda.europa.eu/data/stats2018.
-
- United Nations Office on Drugs, Crime (UNDOC) Convención Única de 1961 sobre Estupefacientes. https://www.unodc.org/pgl/convention_1961_es.pgl.
-
- United Nations Office on Drugs, Crime (UNDOC) Convenio sobre Sustancias Sicotrópicas de 1971. Recuperado de. https://www.unodc.org/pgl/convention_1971_es.pgl.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous